Blood Testing Market in China (Typing, Immunoassay, NAT Testing)

  • ID: 3723861
  • Report
  • Region: China
  • 50 Pages
  • Kalorama Information
1 of 3
Blood Testing Market in China (Typing, Immunoassay, NAT Testing)

With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The report provides market analysis and data on the blood testing market environment in China, including:
  • Blood Center Stations in China by Type (Provincial, Regional, County, Cord, Plasma, Other)
  • China Blood Supply Statistics
  • Blood Supply Centers in Beijing
  • Blood Supply in China (tons)
  • Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)
  • Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
  • Progress of Conversion (Provincial, Regional, County, Plasma Collection) Percentage Using NAT Testing
The report provides province-level statistics on the number of blood centers and the types of blood centers, providing data for the following provinces:
  • Beijing
  • Guangdong
  • Henan
  • Shaanxi
  • Guangxi
  • Heilongjiang
  • Yunnan
Blood Testing Market in China profiles companies in the market and speculates on the best opportunities for test makers. Companies profiled include:
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols
Information for this report was gathered using both primary and secondary research sources. Kalorama Information, working with The Freedonia Group’s office in Beijing, conducted primary research rounds including interviews with national experts and managers at blood collection centers across China. Certain provincial blood centers were a focus of the study to offer a mix of rural and urban provinces, including Shaanxi, Guangdong, Beijing, Henan, Yunnan, and Heilongjiang. The report also benefited from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts’ reports and other sources.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER ONE: EXECUTIVE SUMMARY
Overview
Chinese Healthcare and Blood Banking Environment
Scope and Methodology
Blood Testing Market in China
Major Findings of the Report
CHAPTER TWO: INTRODUCTION
Population Trends and Disease Demographics
Regulation and Policy Challenges for International Companies
CHAPTER THREE: BLOOD TESTING MARKET ENVIRONMENT IN CHINA
Tests Used in Blood Banking
Nucleic-Acid Testing (NAT)
Immunoassays
Typing
Blood Donation and Facilities Data for Specific Provinces
CHAPTER FOUR: MARKET ANALYSIS
Market Overview
CHAPTER FIVE: COMPANY PROFILES
Abbott Laboratories
Bio-Rad Laboratories, Inc.
DiaSorin
Grifols
Immucor
Ortho Clinical Diagnostics
PerkinElmer
Roche
China Health Labs & Diagnostics, Ltd.
Daan Gene Co., Ltd.
LIST OF FIGURES
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: Blood Testing Market in China, 2015 and 2020
Figure 1-2: China’s Blood Supply, 2010-2015
Figure 1-3: Blood Centers in China, Selected Provinces (Beijing, Guangdong, Henan, Shaanxi,Guangxi, Heilongjiang, Yunnan)
CHAPTER TWO: INTRODUCTION
Figure 2-1: Total IVD Market in China, 2015 and 2020
Figure 2-2: Hospitals in China, 2004-2015
CHAPTER THREE: BLOOD TESTING MARKET ENVIRONMENT IN CHINA
Figure 3-1: Blood Center Stations in China by Type (Provincial, Regional, County,Cord, Plasma, Other)
Figure 3-2: China Blood Supply Statistics
Table 3-1: Blood Supply Centers in Beijing
Table 3-2: Blood Centers in Guangdong
Table 3-3: Blood Centers in Henan
Table 3-4: Blood Centers in Shaanxi
Table 3-5: Blood Centers in Guangxi
Table 3-6: Blood Centers in Heilongjiang
Table 3-7: Blood Centers in Yunnan
Figure 3-3: Blood Supply in China (tons)
Figure 3-4: Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)
CHAPTER FOUR: MARKET ANALYSIS
Figure 4-1: Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
Figure 4-2: Progress of Conversion (Provincial, Regional, County, Plasma Collection)Percentage Using NAT Testing
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll